Equity and Share-Based Compensation
|9 Months Ended|
Sep. 30, 2019
|Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]|
|Equity and Share-Based Compensation||
3. Equity and Share-Based Compensation
In June 2019, we issued 404,891 shares of Class A common stock as part of the consideration for an acquisition of a complementary streaming platform focused on Alternative Healing. If the acquired platform maintains profitability and achieves a specific subscriber growth threshold as of June 30, 2020, we may issue up to 139,665 additional shares of Class A common stock as additional consideration. We also issued 79,941 shares of Class A common stock as part of the consideration to acquire over 450 titles of original content that has been integrated into our Alternative Healing channel.
During the first nine months of 2019 and 2018, we recognized approximately $1,597,000 and $1,138,000, respectively, of share-based compensation expense. Total share-based compensation expense is reported in selling and operating expenses and corporate, general and administration expenses on our condensed consolidated statements of operations. During the first nine months of 2018, 45,800 options were exercised with net proceeds of $258,000. No options were exercised during the first nine months of 2019.
The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef